期刊
ARTHRITIS RESEARCH & THERAPY
卷 14, 期 2, 页码 -出版社
BIOMED CENTRAL LTD
DOI: 10.1186/ar3816
关键词
-
类别
资金
- Health Research Council of New Zealand
- New Zealand National Heart Foundation Research Fellowship
Introduction: Two major gout-causing genes have been identified, the urate transport genes SLC2A9 and ABCG2. Variation within the SLC17A1 locus, which encodes sodium-dependent phosphate transporter 1, a renal transporter of uric acid, has also been associated with serum urate concentration. However, evidence for association with gout is equivocal. We investigated the association of the SLC17A1 locus with gout in New Zealand sample sets. Methods: Five variants (rs1165196, rs1183201, rs9358890, rs3799344, rs12664474) were genotyped across a New Zealand sample set totaling 971 cases and 1,742 controls. Cases were ascertained according to American Rheumatism Association criteria. Two population groups were studied: Caucasian and Polynesian. Results: At rs1183201 (SLC17A1), evidence for association with gout was observed in both the Caucasian (odds ratio (OR) = 0.67, P = 3.0 x 10(-6)) and Polynesian (OR = 0.74, P = 3.0 x 10(-3)) groups. Meta-analysis confirmed association of rs1183201 with gout at a genome-wide level of significance (OR = 0.70, P = 3.0 x 10(-8)). Haplotype analysis suggested the presence of a common protective haplotype. Conclusion: We confirm the SLC17A1 locus as the third associated with gout at a genome-wide level of significance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据